Effect of caloric restriction with probiotic supplementation on body composition, quality of life, and psychobiological factors of obese men: A randomized, double-blinded placebo-controlled clinical trial

被引:4
作者
Marques, Camila Guazzelli [1 ]
Quaresma, Marcus V. L. dos Santos [2 ]
Ferracini, Catarina Bortoloto Franca [2 ,3 ]
Carrilho, Filipa Bettencourt Alves [2 ]
Nakamoto, Fernanda Patti [2 ]
Lucin, Glaice Aparecida
Magalha, Ana Carolina Oumatu [1 ,3 ]
Mendes, Gabriela Lima [1 ]
Alvares, Leonardo Azevedo [2 ]
Thomatieli-Santos, Ronaldo Vagner [1 ,3 ]
机构
[1] Univ Fed Sao Paulo, Postgrad Program Psychobiol, Sao Paulo, SP, Brazil
[2] Sao Camilo Univ Ctr, Exercise & Qual Life Lab, Sao Paulo, SP, Brazil
[3] Univ Fed Sao Paulo, Biosci Dept, Santos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Obesity; Caloric restriction; Probiotics; Anxiety; Depression; Quality of life; WEIGHT-LOSS; SLEEP QUALITY; ENERGY-EXPENDITURE; GUT MICROBIOTA; VALIDATION; METAANALYSIS; DEPRESSION; REDUCTION; ANXIETY; SCALE;
D O I
10.1016/j.clnu.2024.12.031
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Obesity is a chronic disease characterized by an excess of fat mass. It is accompanied by a low-grade chronic systemic inflammation state that leads to numerous health disorders. To counteract this scenario, dietary-derived caloric restriction (CR) is the principal intervention for weight loss. Furthermore, probiotic supplementation has gained attention as a co-intervention to optimize weight loss and other health-related factors. As such, we aimed to verify the effect of CR with probiotic supplementation on the body composition, quality of life, sleep quality, anxiety, stress, and depression symptoms of adult men living with obesity. Methods: The study is called the Clinical Study of Obesity and Intestinal Microbiota (ECOMI). It is a randomized, double-blind, placebo-controlled clinical trial involving two parallel groups of stable-weight adult men living with obesity. The inclusion criteria were male individuals aged 25-44 years, with body mass index (BMI) ranging from 30.0 to 39.99 kg/m(2), and stable body mass over the preceding three months. Participants were randomly assigned to two groups: Caloric Restriction with Probiotic (CRPRO) and Caloric Restriction with Placebo (CRPLA). The achieved CR was 30 % of the total daily energy expenditure. Macronutrients were distributed as 50 % carbohydrates, 30 % lipids, and 20 % proteins. Probiotic supplementation was carried out using two sachets/day of 1 g, containing 1 x 10(9) Colony Forming Units (CFU) of each strain: Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus HN001, Lactobacillus paracasei Lpc-37 and Bifidobacterium lactis HN019, totaling 8 billion CFU/day. CR and probiotic (or placebo) supplementation intervention lasted 12 weeks. Body composition and psychobiological-related parameters (e.g., sleep, anxiety, stress, and depression) were assessed at baseline and following 12 weeks of intervention. Data are presented as mean and 95 % confidence interval (CI) and mean difference (MD). Results: The present study applied the per protocol analysis. Thirty-three subjects were evaluated and randomized, but only data from 25 (CRPLA n = 12 vs CRPRO n = 13) participants were included in the final analysis. We verified that CR resulted in weight loss (p < 0.001; eta(2)rho = 0.754) in both CRPLA (MD: -6.30 kg; p < 0.001) and CRPRO (MD: -5.97 kg; p < 0.001), without differences between groups (p = 0.823; eta(2)rho = 0.002). Moreover, both CRPLA (MD: -4.83 kg; p < 0.001) and CRPRO (MD: -5.20 kg; p < 0.001) decreased body fat without difference between groups (p = 0.712; eta(2)rho = 0.006). Regarding obesity-related problems, only the corporeality dimension (p < 0.001; eta(2)rho = 0.474) in both CRPLA (p = 0.028) and CRPRO (p = 0.039) improved. World Health Organization Quality of Life (WHOQoL)-related dimensions were improved for perception (p < 0.001; eta(2)rho = 0.630), satisfaction (p < 0.001; eta(2)rho = 0.778), and psychological domain (p < 0.001; eta(2)rho = 0.567), without differences between groups. Moreover, sleep quality (p < 0.001; eta(2)rho = 0.522) improved in both groups, without differences between groups. Finally, anxiety (p = 0.013; eta(2)rho = 0.250) and depression (p = 0.003; eta(2)rho = 0.345) scores assessed via the Depression, Anxiety and Stress Scale-21 (DASS-21) and the Beck Depression Inventory (BDI-II) (p < 0.001; eta(2)rho = 0.448) improved only in the CRPRO group. Conclusions: Probiotic supplementation did not enhance the effects of caloric restriction on body composition, QoL-, or sleep-related parameters. However, anxiety and depressive symptoms improved only in the CRPRO group, despite no differences between groups after 12 weeks. Further studies are needed to confirm these findings. (c) 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:234 / 249
页数:16
相关论文
共 125 条
[1]   Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo-controlled clinical trials [J].
Almutairi, Rawan ;
Basson, Abigail Raffner ;
Wearsh, Pamela ;
Cominelli, Fabio ;
Rodriguez-Palacios, Alexander .
EUROPEAN JOURNAL OF NUTRITION, 2022, 61 (06) :2853-2871
[2]   Body mass index and sleep disturbances: a systematic review and meta-analysis [J].
Amiri, Sohrab .
POSTEPY PSYCHIATRII I NEUROLOGII, 2023, 32 (02) :96-109
[3]  
Amiri S, 2019, NEUROPSYCHIATRIE, V33, P72, DOI 10.1007/s40211-019-0302-9
[4]  
[Anonymous], project Tj. jamovi 2022. Version 2.3
[5]   The role of probiotics and prebiotics in modulating of the gut-brain axis [J].
Ansari, Fereshteh ;
Neshat, Mehrdad ;
Pourjafar, Hadi ;
Jafari, Seid Mahdi ;
Samakkhah, Shohreh Alian ;
Mirzakhani, Esmaeel .
FRONTIERS IN NUTRITION, 2023, 10
[6]   Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus [J].
Anyiam, Oluwaseun ;
Phillips, Bethan ;
Quinn, Katie ;
Wilkinson, Daniel ;
Smith, Kenneth ;
Atherton, Philip ;
Idris, Iskandar .
CLINICAL NUTRITION, 2024, 43 (08) :1907-1913
[7]   The Complex Associations Among Sleep Quality, Anxiety-Depression, and Quality of Life in Patients with Extreme Obesity [J].
Araghi, Marzieh Hosseini ;
Jagielski, Alison ;
Neira, Iraida ;
Brown, Adrian ;
Higgs, Suzanne ;
Thomas, G. Neil ;
Taheri, Shahrad .
SLEEP, 2013, 36 (12) :1859-1865
[8]   Efficacy of probiotic supplements in improving the symptoms of psychosis, anxiety, insomnia, and anorexia due to amphetamine and methamphetamine use: a randomized clinical trial [J].
Badrfam, Rahim ;
Zandifar, Atefeh ;
Hajialigol, Amirhossein ;
Rashidian, Maryam ;
Schmidt, Norman Brad ;
Morabito, Danielle ;
Qorbani, Mostafa ;
Shahrestanaki, Ehsan ;
Natanzi, Mahboobeh Mehrabani .
PSYCHOPHARMACOLOGY, 2024, 241 (07) :1463-1476
[9]   Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese [J].
Batistelli Vignola, Rose Claudia ;
Tucci, Adriana Marcassa .
JOURNAL OF AFFECTIVE DISORDERS, 2014, 155 :104-109
[10]   A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects [J].
Ben Othman, Rym ;
Ben Amor, Nadia ;
Mahjoub, Faten ;
Berriche, Olfa ;
El Ghali, Chaima ;
Gamoudi, Amel ;
Jamoussi, Henda .
ENDOCRINOLOGY DIABETES & METABOLISM, 2023, 6 (02)